The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, however its future within the broader market now triggers questions about long-term yields . Generic versions are eroding patent protection , leading to concerns that investing in companies significantly dependent to Viagra's once-dominant standing could